Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Steno Diabetes Center, Niels Steensens Vej 2, DK-2820 Gentofte. tmpo@steno.dk
The 1999 WHO classification delineates immune mediated type 1 diabetes from other types of diabetes by the presence of auto-antibodies against beta-cell constituents. The GAD65 auto-antibody test is the method of first choice because it has the highest sensitivity, specificity and positive predictive value and is the most standardized and well-characterized type 1 diabetes related auto-antibody analysis. It is recommended that demonstration of GAD auto-antibodies leads to diagnosis, classification or re-classification of diabetes patients as immune mediated type 1 diabetes.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on